Current understanding on the role of retinal pigment epithelium and its pigmentation

U Schraermeyer, K Heimann - Pigment cell research, 1999 - Wiley Online Library
Retinal pigment epithelium (RPE) is a monolayer of cuboidal cells that is strategically placed
between the rod and cone photoreceptors and the vascular bed of the choriocapillaris. It has …

[HTML][HTML] From PGF2α-Isopropyl Ester to Latanoprost: A Review of the Development of Xalatan The Proctor Lecture

JW Stjernschantz - Investigative Ophthalmology & Visual …, 2001 - iovs.arvojournals.org
The research that led to the concept of using prostaglandins for reduction of intraocular
pressure (IOP) has been discussed by Bito and goes back to the early 1980s, when it was …

The side effects of the prostaglandin analogues

G Holló - Expert opinion on drug safety, 2007 - Taylor & Francis
In the last decade topically applied prostaglandin F2α analogues (bimatoprost, latanoprost,
travoprost and unoprostone) have become widely used as a means to reduce elevated …

Pharmacological characteristics of AFP-168 (tafluprost), a new prostanoid FP receptor agonist, as an ocular hypotensive drug

Y Takagi, T Nakajima, A Shimazaki… - Experimental eye …, 2004 - Elsevier
To evaluate the pharmacological characteristics of AFP-168 (tafluprost), a new
prostaglandin (PG) F2α derivative, we examined its receptor-binding affinities, intraocular …

Effects of common topical antiglaucoma medications on the ocular surface, eyelids and periorbital tissue

JJ Servat, CR Bernardino - Drugs & aging, 2011 - Springer
Glaucoma affects millions of people around the world. With the baby boom generation
aging, the number of people affected by primary open-angle glaucoma in the US is expected …

Mechanism and clinical significance of prostaglandin-induced iris pigmentation

JW Stjernschantz, DM Albert, DN Hu, F Drago… - Survey of …, 2002 - Elsevier
The new glaucoma drugs latanoprost, isopropyl unoprostone, travoprost, and bimatoprost
cause increased pigmentation of the iris in some patients. The purpose of the present article …

A 5-Year, Multicenter, Open-Label, Safety Study of Adjunctive LatanoprostTherapy for Glaucoma

A Alm, J Schoenfelder, J McDermott - Archives of ophthalmology, 2004 - jamanetwork.com
Objective To evaluate the 5-year safety and efficacy of adjunctive 0.005% latanoprostonce
daily. Methods Patients with primary open-angle or exfoliation glaucoma who completeda 3 …

New fluoroprostaglandin F2α derivatives with prostanoid FP-receptor agonistic activity as potent ocular-hypotensive agents

T Nakajima, T Matsugi, W Goto… - Biological and …, 2003 - jstage.jst.go.jp
MATERIALS AND METHODS Materials Prostarumon® F injection 1000 (1mg/ml PGF2a)
was obtained from Ono Pharmaceutical Co., Ltd.(Osaka, Japan), while cloprostenol was …

Prostaglandin analogues in the treatment of glaucoma

C Lindén, A Alm - Drugs & aging, 1999 - Springer
Prostaglandin (PG) analogues are a new class of ocular hypotensive drugs that have been
developed for the treatment of open angle glaucoma. Two of these drugs, latanoprost and …

Ocular factors relevant to anti-glaucomatous eyedrop-related keratoepitheliopathy

K Inoue, K Okugawa, S Kato, Y Inoue… - Journal of …, 2003 - journals.lww.com
Purpose To evaluate the ocular factors contributing to keratoepitheliopathy in glaucoma
patients treated with or without anti-glaucomatous eyedrops, and the influences of each anti …